Zimmer Biomet Holdings Stock News

Investors are optimistic about Zimmer Biomet (ZBH) given robust demand for its ROSA robotics line and continued investment in profitable business areas.

Companies In The News Are: ZBH, CCL, UNH, CHNG, BA.

Zimmer Biomet (ZBH) expects to face an adverse pricing impact in the first half of 2022, which is being compared to the non-VBP first half of 2021.

Zimmer Biomet (ZBH) expects to face an adverse pricing impact in the first half of 2022, which is being compared to the non-VBP first half of 2021.

It's just as important to know what dividend stocks to avoid as it is to know which ones to buy, especially in the current market. The post 7 Dividend Stocks to Avoid in the Rotation to Safety appeare

Zimmer Biomet ( ZBH , Financial) is a global leader in musculoskeletal health care. The company designs, manufactures and markets orthopedic reconstructive implants and supplies surgical equipment for

Analysts have provided the following ratings for Zimmer Biomet Holdings (NYSE:ZBH) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 5 2 7 2

WalkAI adds powerful predictive analytic capabilities to ZBEdge, Zimmer Biomet's (ZBH) suite of integrated digital and robotic technologies.

WalkAI adds powerful predictive analytic capabilities to ZBEdge, Zimmer Biomet's (ZBH) suite of integrated digital and robotic technologies.

Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?

Las Vegas, USA, March 08, 2022 (GLOBE NEWSWIRE) -- Surgical Robotic Systems Market to Grow at a Significant CAGR of 11.5% by 2026, as per DelveInsight''s Analysis The demand for Surgical Robotic Systems is witnessing a huge surge due to increasing surgical procedures which can be attributed to various factors such as increasing geriatric population who form a big part of the at-risk population for prostate cancer, valvular diseases, endometriosis among other diseases leading to a direct increase in the Surgical Robotic Systems Market. DelveInsight''s Surgical Robotic Systems Market Insights and Forecast report provides the current and forecast Surgical Robotic Systems Market, upcoming innovation in the devices, individual market shares, challenges, drivers, and barriers, market trends, and key competitors in the Surgical Robotic Systems Market. Some of the essential factors from the Surgical Robotic Systems Market report: As per DelveInsight analysis, in terms of revenue share, North America is predicted to register the fastest growth and occupy the largest Surgical Robots market share.

Upgrades Barclays upgraded the previous rating for Equitrans Midstream Corp (NYSE:ETRN) from Underweight to Equal-Weight. Equitrans Midstream earned $0.07 in the fourth quarter, compared to $0.31 in

Zimmer Biomet Holdings (NYSE:ZBH) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 7 2 8 2 0 L

Zimmer Biomet Holdings (NYSE: ZBH ) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 7 2 8 2 0 Last 30D 0 0 1 0 0 1M Ago 3 2 4 1 0 2M Ago 1 0 2 1 0 3M Ago 3 0 1 0 0 According to 19 analyst offering 12-month price targets in the last 3 months, Zimmer Biomet Holdings has an average price target of $136.84 with a high of $165.00 and a low of $111.00. Below is a summary of how these 19 analysts rated Zimmer Biomet Holdings over the past 3 months. … Full story available on Benzinga.com